Viewing nowEsomeprazole Magnesium 40mg (Esomeprazole magnesium dihydrate)
Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Iworld Pharmaceutical Co., Ltd.

MFDS item code 201604347 · Approved 2016.07.14
Treatment of reflux disease, gastrointestinal disorders (including eradication therapy, ulcers, and drug-induced disorders), and Zollinger-Ellison syndrome
This medication is used for the treatment of gastroesophageal reflux disease, particularly for long-term maintenance therapy to prevent relapse in patients with erosive reflux esophagitis. It is also effective in alleviating symptoms of gastroesophageal reflux disease without esophagitis. It is used in conjunction with antibiotic therapy for the eradication of Helicobacter pylori, assisting in the treatment and prevention of recurrence of benign duodenal ulcers and peptic ulcers. The medication is applicable for short-term treatment of symptoms of the upper gastrointestinal tract induced by non-steroidal anti-inflammatory drugs (both non-selective and selective COX-2 inhibitors). Furthermore, it is utilized in the treatment of gastric ulcers in patients receiving long-term non-steroidal anti-inflammatory drug treatment and in the prevention of gastric and duodenal ulcers. Additionally, it is effective for the treatment of Zollinger-Ellison syndrome and for maintenance therapy to prevent rebleeding from gastric ulcers or duodenal ulcers. It is widely used for various gastrointestinal diseases.
1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. - Long-term maintenance therapy to prevent relapse in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. On-demand use to control recurrent symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment. 2) Combination therapy with antibiotics for eradication of Helicobacter pylori Administer this medication 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, heartburn) associated with the use of nonsteroidal anti-inflammatory drugs (nonselective or selective COX-2 inhibitors) - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting more than 4 weeks have not been conducted. 4) Patients requiring continuous treatment with nonsteroidal anti-inflammatory drugs - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug treatment: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug treatment: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should then be adjusted for each patient, and treatment should continue for as long as clinical symptoms are present. Clinical data indicate that most patients can be controlled with doses of 80 ∼ 160 mg daily. Doses above 80 mg daily should be divided and taken twice daily. 6) Maintenance therapy following induction of prevention of rebleeding from gastric or duodenal ulcers by intravenous injection Administer 40 mg once daily for 4 weeks following induction of prevention of rebleeding from gastric or duodenal ulcers by intravenous injection. 4. Renal impairment No dosage adjustment is necessary. Use with caution because there is limited experience in patients with severe renal impairment. 5. Hepatic impairment No dosage adjustment is necessary in patients with mild to moderate hepatic impairment. Patients with severe hepatic impairment should not exceed a dose of 20 mg of this medication. 6. Elderly patients No dosage adjustment is necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. If esophagitis has not healed or symptoms persist, continue treatment for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurrent symptoms may be controlled with 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. On-demand use to control recurrent symptoms is not recommended for patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug treatment. 3. Children under 12 years There is no experience with administration of this medication to children under 12 years.
This medication should not be administered to patients with allergies or hypersensitivity to specific ingredients or benzimidazole derivatives. Patients with hypersensitivity to penicillin or macrolide antibiotics should also avoid using this medication. Patients taking certain heart-related medications or antiviral drugs, as well as breastfeeding women, should not use this medication. Rare side effects such as blood cell count reductions, hypersensitivity reactions, and hypomagnesemia may occur when taking this medication, requiring caution. Various symptoms, including headache, dizziness, gastrointestinal disturbances, and skin rashes, may manifest, and in severe cases, consultation with a specialist is recommended. Long-term use requires regular monitoring, and it is important to inform your doctor about potential drug interactions that may alter the effects of other medications. Particularly with antibiotic combinations, it is critical to thoroughly review the instructions, as some medications may be contraindicated or require dosage adjustments when used together. This medication may reduce gastric acidity, which can increase the risk of bacterial infections; therefore, if symptoms of diarrhea persist, it is advisable to consult healthcare professionals. Patients at risk of osteoporosis or fractures should exercise caution when taking this medication over extended periods. Patients with genetic issues such as fructose intolerance should avoid taking this medication, and periodic blood tests are necessary due to the potential for hypomagnesemia with long-term use. Limited data exists on the use of this medication during pregnancy, so pregnant women should consult their doctor before use, and breastfeeding women should avoid taking it. In cases of overdose, no specific antidote exists, so treatment should be symptomatic and general management is required. This medication must be kept out of reach of children and transferring it to other containers can compromise its quality.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylaxis, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, agitation, confusion, depression, aggression, hallucinations, headache, dizziness, paresthesia, drowsiness, dysgeusia, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal distension, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, elevated liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, hair loss, photosensitivity, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized pustular psoriasis, drug reactions with eosinophilia and systemic symptoms, fracture, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, asthenia, increased sweating, Clostridium difficile-associated diarrhea, abdominal bloating, allergic reactions, back pain, chest pain, retrosternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, generalized edema, leg edema, malaise, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, goiter, irritable bowel syndrome, worsening constipation, dyspepsia, dysphagia, gastrointestinal motility disorders, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, elevated serum gastrin, lingual disorders, lingual edema, ulcerative stomatitis, vomiting, ear pain, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nasal bleeding, leukocytosis, leukopenia, thrombocytopenia, bilirubinemia, liver function abnormalities, elevated ALT, elevated AST, diabetes, hyperuricemia, elevated ALP, thirst, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, arthropathy, seizures, fibromyalgia syndrome, hernia, polymyalgia rheumatica, arthralgia, anorexia, apathy, increased appetite, confusion, worsening depression, hypertonia, agitation, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremor, dizziness, visual field loss, paresthesia, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, abnormal olfaction, taste loss, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infection, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual abnormalities, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyp or nodule, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, discoid lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis, myalgia, elevated creatine kinase, elevated myoglobin in serum and urine
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1°C and 30°C. Proper storage will help preserve the effectiveness and safety of the medication.
Pink rectangular film-coated tablet
28 tablets (14 tablets/Alu-Alu X2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Iworld Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.